PROFOUND MEDICAL CORP. Foreign Currency Transaction Gain (Loss), before Tax
PROFOUND MEDICAL CORP. (PROF) reported Foreign Currency Transaction Gain (Loss), before Tax of $1.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $1.25M.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $616.00K, a 1521.05% increase year-over-year.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$940.00K, a 133.24% decline year-over-year.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $935.00K.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$2.13M, a 156.04% decline from fiscal 2024.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for fiscal 2024 was $3.81M.
- PROFOUND MEDICAL CORP. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$575.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-06 | $1.86M 10-Q · filed 2026-08-06 | $921.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $616.00K 10-Q · filed 2026-05-07 | -$324.00K derived: sum of 2 quarters · filed 2026-05-07 | $611.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$5.00K derived: sum of 2 quarters · filed 2026-03-05 | -$2.17M derived: sum of 3 quarters · filed 2026-08-06 | -$2.13M 10-K · filed 2026-03-05 |
| 2025-09-30 | $935.00K 10-Q · filed 2025-11-13 | -$1.23M derived: sum of 2 quarters · filed 2026-08-06 | -$1.19M 10-Q · filed 2025-11-13 | $1.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.17M 10-Q · filed 2026-08-06 | -$2.13M 10-Q · filed 2026-08-06 | $698.00K derived: sum of 3 quarters · filed 2026-08-06 | $288.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-07 | $2.87M derived: sum of 2 quarters · filed 2026-05-07 | $2.46M derived: sum of 3 quarters · filed 2026-05-07 | $2.98M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.42M derived: sum of 2 quarters · filed 2026-03-05 | $2.94M derived: sum of 3 quarters · filed 2026-03-05 | $3.81M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$410.00K 10-Q · filed 2025-11-13 | $110.00K derived: sum of 2 quarters · filed 2025-11-13 | $980.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $520.00K 10-Q · filed 2025-08-14 | $1.39M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $870.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$575.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |